Christopher da Costa
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
-
- Vaccine Coverage and Hesitancy
Papers in
-
- Tuberculosis Research and Epidemiology 5
- SARS-CoV-2 and COVID-19 Research 3
- Antifungal resistance and susceptibility 2
- Clostridium difficile and Clostridium perfringens research 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Infective Endocarditis Diagnosis and Management 2
- Co-authors
- Barry Walker (1 shared paper)Aurelio Bonavia (1 shared paper)Alison M. Elliott (1 shared paper)Saroj Khanolkar-Young (1 shared paper)Keith McAdam (1 shared paper)K. Wasunna (1 shared paper)A.H. Quoraishi (1 shared paper)Arthur Morris (1 shared paper)
- Journals
- Hormone and Metabolic Research (2 papers)International Journal of Infectious Diseases (2 papers)Open Forum Infectious Diseases (2 papers)Human Vaccines & Immunotherapeutics (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Christopher da Costa
17 papers receiving 262 citations
Peers
Comparison fields: 5 of 75
- Infectious Diseases 151
- Health 45
- Epidemiology 133
- Clinical Biochemistry 21
- Immunology 49
Countries citing papers authored by Christopher da Costa
This map shows the geographic impact of Christopher da Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher da Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher da Costa more than expected).
Fields of papers citing papers by Christopher da Costa
This network shows the impact of papers produced by Christopher da Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher da Costa. The network helps show where Christopher da Costa may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher da Costa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 43 | |
| 2 | 2021 | 33 | |
| 3 | 1993 | 29 | |
| 4 | 1996 | 23 | |
| 5 | 2012 | 20 | |
| 6 | 2014 | 17 | |
| 7 | 2016 | 17 | |
| 8 | 1993 | 16 | |
| 9 | 2014 | 15 | |
| 10 | 2012 | 11 | |
| 11 | 2024 | 10 | |
| 12 | 2013 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2017 | 6 | |
| 15 | 2010 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2013 | 1 |
About Christopher da Costa
Christopher da Costa is a scholar working on Infectious Diseases, Epidemiology, Health, Sociology and Political Science and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 265 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Vaccine Coverage and Hesitancy (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Infective Endocarditis Diagnosis and Management (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antifungal resistance and susceptibility (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Infectious Diseases (151 citations), Health (45 citations), Epidemiology (133 citations), Clinical Biochemistry (21 citations) and Immunology (49 citations). Christopher da Costa has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Barry Walker, Aurelio Bonavia, Alison M. Elliott, Saroj Khanolkar-Young, Keith McAdam, K. Wasunna, A.H. Quoraishi, Arthur Morris, Benjamin A. Lipsky and Ozlem Equils. Their work appears in journals such as Hormone and Metabolic Research, International Journal of Infectious Diseases, Open Forum Infectious Diseases, Human Vaccines & Immunotherapeutics and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.